Finance

Beta
Lists
MSCL:TSE
Satellos Bioscience Inc
CA$8.31
-14.06%
(-1.36) 1D
Jun 3, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MSCL...
Open
CA$9.80
High
CA$9.80
Low
CA$8.31
Mkt. cap
173.13M
Avg. vol.
10.92K
Volume
31.09K
52-wk high
CA$18.98
52-wk low
CA$6.24
EPS
-CA$2.51
Beta
1.18
Shares outstanding
20.83M
No. of employees
20
Open
CA$9.80
High
CA$9.80
Low
CA$8.31
Mkt. cap
173.13M
Avg. vol.
10.92K
Volume
31.09K
52-wk high
CA$18.98
52-wk low
CA$6.24
EPS
-CA$2.51
Beta
1.18
Shares outstanding
20.83M
No. of employees
20
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to MSCL in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for MSCL in the last 3 months.
Highest
Current $8.31
$40.00 (+381.35%)
Average
$20.61 (+148.01%)
Lowest
$11.00 (+32.37%)
News stories
From sources across the web
About Satellos Bioscience Inc
CEO-
Employees20
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.53 / -$0.59
+10.17%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
4.44M
3.99M
-11.46M
7.31M
Cost of revenue
4.44M
3.99M
-11.46M
7.31M
Research and development expenses
-
-
16.92M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93M
1.97M
2.19M
2.73M
Operating expense
1.93M
1.97M
19.11M
2.73M
Total operating expenses
6.37M
5.97M
7.65M
10.04M
Operating income
-6.37M
-5.97M
-7.65M
-10.04M
Other non operating income
-
-
-
-
EBT including unusual items
-5.58M
-5.80M
-7.24M
-9.74M
EBT excluding unusual items
-5.58M
-5.80M
-7.24M
-9.74M
Income tax expense
32.00K
19.00K
58.00K
33.00K
Effective tax rate
-0.57%
-0.33%
-0.80%
-0.34%
Other operating expenses
-
-
-
-
Net income
-5.61M
-5.82M
-7.30M
-9.77M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.50
-0.53
Interest and investment income
362.00K
349.00K
256.00K
421.00K
Interest expense
-
-
-
-
Net interest expenses
362.00K
349.00K
256.00K
421.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.37M
-5.96M
-7.65M
-10.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more